Linical Co., Ltd.
2183
Rank in Stocks
#25117
Linical Co., Ltd., a global contract research organization provides full... Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Share Price
$1.25
Last synced: 2026-11-10
Market Cap
$28.16M
Change (1 day)
0.51%
Change (1 year)
-44.80%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Linical Co., Ltd. (2183)
Category
Healthcare
EPS for Linical Co., Ltd. (2183)
EPS as of June 2026 TTM: $-1.06
According to Linical Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-1.06. At the end of 2025 the company had an EPS of $-0.16, a decrease compared to its 2024 EPS of $0.10.
EPS history for Linical Co., Ltd. from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.06 | 564.00% |
| 2025 | $-0.16 | -260.81% |
| 2024 | $0.10 | -70.44% |
| 2023 | $0.33 | 16.49% |
| 2022 | $0.29 | 33.16% |
| 2021 | $0.22 | 8.55% |
| 2020 | $0.20 | -11.99% |
| 2019 | $0.23 | -57.89% |
| 2018 | $0.54 | -5.99% |
| 2017 | $0.57 | 10.00% |
| 2016 | $0.52 | 224.58% |
| 2015 | $0.16 | -16.33% |
| 2014 | $0.19 | -33.48% |
| 2013 | $0.29 | 28.09% |
| 2012 | $0.22 | 200.27% |
| 2011 | $0.07 | -37.02% |
| 2010 | $0.12 | -4.20% |
| 2009 | $0.12 | 8,742.86% |
| 2008 | 0.00 | 180.00% |
| 2007 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | -1,887.46% |
US
|
|
| $6.12 | -676.05% |
US
|
|
| $1.38 | -229.62% |
CN
|
|
| $14.83 | -1,495.90% |
US
|
|
| $5.09 | -579.10% |
US
|
Questions about Linical Co., Ltd.'s earnings per share (EPS)
What is Linical Co., Ltd.'s earnings per share (EPS)?
Linical Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-1.06, as of Jun 2026.
What was Linical Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Linical Co., Ltd.'s earnings per share (EPS) was $-0.16, compared with $0.10 in 2024.
How has Linical Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Linical Co., Ltd.'s earnings per share (EPS) was highest in 2023 ($0.33) and lowest in 2025 ($-0.16).
How does Linical Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Linical Co., Ltd.'s earnings per share (EPS) ($-1.06) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.